A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs
Version of Record online: 26 NOV 2013
© 2013 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Diabetes, Obesity and Metabolism
Volume 16, Issue 3, pages 273–275, March 2014
How to Cite
Funch, D., Gydesen, H., Tornøe, K., Major-Pedersen, A. and Chan, K. A. (2014), A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs. Diabetes, Obesity and Metabolism, 16: 273–275. doi: 10.1111/dom.12230
- Issue online: 4 FEB 2014
- Version of Record online: 26 NOV 2013
- Accepted manuscript online: 6 NOV 2013 09:55PM EST
- Manuscript Accepted: 29 OCT 2013
- Manuscript Revised: 13 AUG 2013
- Manuscript Received: 24 JUL 2013